News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
FRATES JAMES M
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 08/24/2023 |
4
| FRATES JAMES M (CFO) has filed a Form 4 on Amylyx Pharmaceuticals, Inc.|
Txns:
| Exercised 18,165 options to buy
@ $6.88, valued at
$125k
|
|
| 06/16/2023 |
4
| FRATES JAMES M (Director) has filed a Form 4 on Sage Therapeutics, Inc.|
Txns:
| Granted 10,000 options to buy
@ $56.1, valued at
$561k
|
|
| 05/18/2023 |
4
| FRATES JAMES M (CFO) has filed a Form 4 on Amylyx Pharmaceuticals, Inc.|
Txns:
| Sold 32,000 shares
@ $26.9266, valued at
$861.7k
Sold 500 shares
@ $27.6, valued at
$13.8k
Exercised 32,500 options to buy
@ $6.88, valued at
$223.6k
|
|
| 05/16/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 04/26/2023 |
4/A
| Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] |
| 04/26/2023 |
3/A
| Form 3/A - Initial statement of beneficial ownership of securities: [Amend] |
| 03/24/2023 |
4/A
| FRATES JAMES M (CFO) has filed a Form 4 on Amylyx Pharmaceuticals, Inc.|
Txns:
| Sold 30,796 shares
@ $31.8593, valued at
$981.1k
Sold 1,704 shares
@ $32.4649, valued at
$55.3k
Granted 21,667 shares
@ $0
Granted 97,500 options to buy
@ $32.08, valued at
$3.1M
Exercised 32,500 options to buy
@ $6.88, valued at
$223.6k
|
|
| 03/20/2023 |
4
| FRATES JAMES M (CFO) has filed a Form 4 on Amylyx Pharmaceuticals, Inc.|
Txns:
| Sold 30,796 shares
@ $31.8593, valued at
$981.1k
Sold 1,704 shares
@ $32.4649, valued at
$55.3k
Granted 21,667 shares
@ $0
Granted 97,500 options to buy
@ $32.08, valued at
$3.1M
|
|
| 03/16/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 01/10/2023 |
4
| FRATES JAMES M (CFO) has filed a Form 4 on Amylyx Pharmaceuticals, Inc.|
Txns:
| Sold 1,836 shares
@ $36.0789, valued at
$66.2k
Sold 822 shares
@ $36.7888, valued at
$30.2k
|
|
| 01/04/2023 |
4
| FRATES JAMES M (CFO) has filed a Form 4 on Amylyx Pharmaceuticals, Inc.|
Txns:
| Exercised 5,000 options to buy
@ $6.88, valued at
$34.4k
|
|
| 06/17/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/28/2022 |
4
| FRATES JAMES M (CFO) has filed a Form 4 on Amylyx Pharmaceuticals, Inc.|
Txns:
| Granted 25,000 options to buy
@ $19.625, valued at
$490.6k
|
|
| 01/10/2022 |
4
| FRATES JAMES M (CFO) has filed a Form 4 on Amylyx Pharmaceuticals, Inc.|
Txns:
| Granted 31,667 shares
@ $0
Granted 142,500 options to buy
@ $19, valued at
$2.7M
|
|
| 01/06/2022 |
3
| FRATES JAMES M (CFO) has filed a Form 3 on Amylyx Pharmaceuticals, Inc. |
| 06/17/2021 |
4
| FRATES JAMES M (Director) has filed a Form 4 on Sage Therapeutics, Inc.|
Txns:
| Bought 1,810 shares
@ $55.102, valued at
$99.7k
|
|
| 06/11/2021 |
4
| FRATES JAMES M (Director) has filed a Form 4 on Sage Therapeutics, Inc.|
Txns:
| Granted 10,000 options to buy
@ $76.09, valued at
$760.9k
|
|
| 06/11/2020 |
4
| FRATES JAMES M (Director) has filed a Form 4 on Sage Therapeutics, Inc.|
Txns:
| Granted 10,000 options to buy
@ $36.47, valued at
$364.7k
|
|
| 05/14/2020 |
4
| FRATES JAMES M (SVP, Alks Inc; CFO ALKS) has filed a Form 4 on Alkermes plc.|
Txns:
| Exercised 21,983 options to buy
@ $11.74, valued at
$258.1k
|
|
| 03/03/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/24/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/18/2020 |
4
| FRATES JAMES M (SVP, Alks Inc; CFO ALKS) has filed a Form 4 on Alkermes plc.|
Txns:
| Paid exercise price by delivering 1,172 shares
@ $17.77, valued at
$20.8k
Paid exercise price by delivering 904 shares
@ $17.77, valued at
$16.1k
Exercised 3,375 options to buy
@ $0
Exercised 3,000 options to buy
@ $0 |
|
| 02/04/2020 |
5
| FRATES JAMES M (Director) has filed a Form 5 on Sage Therapeutics, Inc. |
| 09/17/2019 |
4
| FRATES JAMES M (SVP, Alks Inc; CFO ALKS) has filed a Form 4 on Alkermes plc.|
Txns:
| Gifted 2,000 shares
@ $0
Exercised 20,000 options to buy
@ $11.74, valued at
$234.8k
|
|
| 08/16/2019 |
4
| FRATES JAMES M (Director) has filed a Form 4 on Sage Therapeutics, Inc.|
Txns:
| Gifted 1,200 shares
@ $0
Gifted 500 shares
@ $0
Sold 8,000 shares
@ $160.58, valued at
$1.3M
Exercised 8,000 options to buy
@ $28.35, valued at
$226.8k
|
|
| 06/06/2019 |
4
| FRATES JAMES M (Director) has filed a Form 4 on Sage Therapeutics, Inc.|
Txns:
| Granted 10,000 options to buy
@ $177.41, valued at
$1.8M
|
|
| 05/06/2019 |
4
| FRATES JAMES M (Director) has filed a Form 4 on Sage Therapeutics, Inc.|
Txns:
| Sold 8,000 shares
@ $162.22, valued at
$1.3M
Exercised 8,000 options to buy
@ $8.92, valued at
$71.4k
|
|
| 03/04/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/27/2019 |
4
| FRATES JAMES M (SVP, Alks Inc; CFO ALKS) has filed a Form 4 on Alkermes plc.|
Txns:
| Paid exercise price by delivering 772 shares
@ $33.92, valued at
$26.2k
Exercised 2,625 options to buy
@ $0 |
|
| 02/25/2019 |
4
| FRATES JAMES M (SVP, Alks Inc; CFO ALKS) has filed a Form 4 on Alkermes plc.|
Txns:
| Granted 90,600 options to buy
@ $32.57, valued at
$3M
Granted 23,300 options to buy
@ $0 |
|
| 02/19/2019 |
4
| FRATES JAMES M (SVP, Alks Inc; CFO ALKS) has filed a Form 4 on Alkermes plc.|
Txns:
| Paid exercise price by delivering 1,098 shares
@ $32.54, valued at
$35.7k
Paid exercise price by delivering 875 shares
@ $32.54, valued at
$28.5k
Exercised 3,375 options to buy
@ $0
Exercised 3,000 options to buy
@ $0 |
|
| 01/24/2019 |
4
| FRATES JAMES M (Director) has filed a Form 4 on Sage Therapeutics, Inc.|
Txns:
| Sold 7,500 shares
@ $134.81, valued at
$1M
Exercised 7,500 options to buy
@ $8.92, valued at
$66.9k
|
|
| 12/11/2018 |
4
| FRATES JAMES M (SVP, Alks Inc; CFO ALKS) has filed a Form 4 on Alkermes plc.|
Txns:
| Granted 5,500 shares
@ $0
Paid exercise price by delivering 2,445 shares
@ $34.01, valued at
$83.2k
|
|
| 08/23/2018 |
4
| FRATES JAMES M (Director) has filed a Form 4 on Sage Therapeutics, Inc.|
Txns:
| Gifted 700 shares
@ $0
Gifted 65 shares
@ $0 |
|
|
|
|